A modular cell-culture platform demonstrates accelerated process development.
Thomas Wucherpfennig
Advertisement
Thomas Wucherpfennig is scientist, cell culture development at Boehringer Ingelheim Pharma GmbH & Co. KG.
Articles by Thomas Wucherpfennig
Advertisement
Latest Updated Articles
Platform Approach Speeds Process DevelopmentPublished: April 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
